Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03202940
Title A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Alectinib + Cobimetinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts general Hospital Recruiting Boston Massachusetts 02114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field